Martine E D Chamuleau

19PUBLICATIONS
85CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMedical devicesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 26, 2026
Molecular Profiling and Disease Tracking of Post-transplant Lymphoproliferative Disorders using Cell-free DNA.

|Dec 12, 2025
Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma.

Steven Wang, Marcel Nijland, Leonie Strobbe

|Oct 06, 2025
Cytoskeletal dynamics and mitochondrial rearrangements drive cell fate upon antibody-induced complement activation in DLBCL.

Hilma J van der Horst, Tamás Csikós, Marjolein Quik

|Jul 08, 2025
Artificial intelligence modelling of tyrosine kinase inhibitors at risk of malabsorption and bioavailability-enhancing strategies.

Daan W Huntjens, Olivier J M Béquignon, Stefanie D Krens

|Nov 27, 2024
Delineating MYC-Mediated Escape Mechanisms from Conventional and T Cell-Redirecting Therapeutic Antibodies.

Anna Vera de Jonge, Tamás Csikós, Merve Eken

|Sep 12, 2024
Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma.

Carolien C H M Maas, David van Klaveren, Müjde Durmaz

Pageof 4

Frequent Collaborators

5 joint publications

Avinash G Dinmohamed

5 joint publications

Marcel Nijland

4 joint publications

Müjde Durmaz

3 joint publications

Mirian Brink